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doi:10.1016/j.ejvs.2009.04.015Abstract Objective: To analyse the early and mid-term outcomes of endovascular repair of
Stanford type B aortic dissection (B-AD) and to compare the outcomes between acute type
B aortic dissection (AAD) and chronic type B aortic dissection (CAD).
Methods: The cohort included 121 consecutive patients undergoing endovascular repair for
AAD (group A, nZ 72) and CAD (group B, nZ 49) between January 2001 and December
2006. Follow-up with clinical examinations and computed tomography (CT) was performed
post-intervention at 1, 6 and 12 months, and then yearly thereafter.
Results: In groups A and B, respectively, the procedure success rates were 88.9% and 77.6%;
the rates of postoperative endoleak were 11.1% and 22.4%; the 30-day mortality rates were
1.4% and 8.2%; and the 30-day stroke rates were 4.2% and 2.0%. No postoperative spinal cord
ischaemia (SCI) was observed. The mean follow-up periods for groups A and B were 14.4 11.0
months and 22.1 20.8 months, respectively. Late mortality was 1.5% in group A and 4.8% in
group B. In group A, the rates of complete false lumen (FL) thrombosis at 1 month, 1 year and 2
years postoperatively were 32.3%, 51.4% and 53.8%, respectively, and in group B, 26.2%, 44.8%,
and 50.0%, respectively.
Conclusion: Endovascular repair is feasible for both AAD and CAD, with favourable short- and
mid-term outcomes.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.13302224168; fax: þ86 020
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ty for Vascular Surgery. PublisheThe optimal therapy for both acute type B aortic dissection
(AAD) and chronic type B aortic dissection (CAD) remains
controversial. The current consensus is to manage the AAD
with intensive medical treatment, while surgery is reservedd by Elsevier Ltd. All rights reserved.
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tension, persistent back or chest pain and end-organ
ischaemia.1,2 However, traditional open surgery for AAD is
associated with high mortality and morbidity. The IRAD
study3 enrolled 83 patients who required open surgery for
AAD and showed that the in-hospital mortality was 29.3%,
and the rate of neurological deficits was 23.2%. The endo-
vascular repair of AAD and CAD introduced in 19994,5 has
been proven to be an effective and less-invasive therapy,
associated with relatively low mortality and low rates of
complications.6,7 In this study, we present the results of 121
patients with B-AD who received endovascular repair at our
centre, and compared the outcomes between AAD and CAD.
Methods
Indications for endovascular treatment of AAD were as
follows: (1) persistent back or chest pain, (2) uncontrol-
lable hypertension, (3) malperfusion syndrome, (4) rupture
and (5) a maximal aortic diameter 5 cm. The indications
for CAD were: (1) pseudo-aneurysm with diameter 5 cm or
rapid enlargement >5 mm per year and (2) acute
symptoms.
Procedure
Details of the procedure have been described previously.4
In our patient cohort, trans-oesophageal echocardiography
(TEE) was not used to guide the stent positioning. When the
length of proximal landing zone (PLZ) was shorter than
2 cm, computed tomography angiography (CTA), magnetic
resonance angiography (MRA) or digital subtraction angi-
ography (DSA) was performed to study the contralateral
vertebral artery, the vertebrobasilar system and the Willis
circle to assess the risk of left subclavian artery (LSA)
coverage. If the exclusion of the left vertebral artery could
be compensated sufficiently, the LSA was intentionally
covered without reconstruction; otherwise, reconstruction
of LSA prior to intervention was performed.
Definitions
B-AD was considered as acute when presenting within 14
days of the beginning of the symptoms and chronic after 14
days. Procedure success was defined as complete coverage
of the primary entry tear without a type I or III endoleak at
the end of the procedure. Type I endoleak was defined as
blood flow into the false lumen (FL) due to incomplete seal
or ineffective seal at one extremity of the stent graft.
Complete FL thrombosis was defined as presence of
thrombus without blood flow identified in the FL. Partial FL
thrombosis was defined as the concurrent presence of both
blood flow and thrombus in the FL.
Statistical analysis
Continuous variables are expressed as mean standard
deviation, while categorical data are presented as
percentages. A comparison between continuous variables
was performed by Student’s t-test. Categorical variableswere analysed by chi-square and Fisher’s exact tests.
Cumulative survival rates were calculated using Kaplane
Meier analysis and compared by the log-rank test. A P-value
<0.05 was considered statistically significant. Statistical
software SPSS 11.5 (Chicago, IL, USA) was used for all the
statistical analyses.
Results
Patients
Among 149patientswith aortic dissection (including 28 typeA
aortic dissections and 121 B-ADs) treated at our centre
between January 2001 and December 2006, a total of 121
patientswhounderwent theendovascular repair for B-ADwas
included in this study. In this cohort, 72 patients were treated
during the acute phase (AAD; group A) while 49 patients were
treated during the chronic phase (CAD; group B). The demo-
graphics of both groups are presented in Table 1. The two
groupshadcomparable co-morbid conditions, except that the
incidence of malperfusion syndrome was significantly higher
in group A than in group B (20.8% vs. 0%, pZ 0.002). No
transient dialysis was required for the five patients who pre-
sented with mild renal insufficiency. No significant differ-
ences were observed between the two groups related to age,
male gender, hypertension, chronic renal failure, chronic
heart failure,aortic rupture,pneumonia, cardiacarrhythmia,
Marfan syndrome, tumour or the number of tears.
Procedural outcome
In this cohort, 130 stents were used: 103 Talent grafts
(Medtronic Inc., Santa Rosa, California, USA), 12 Zenith
grafts (COOK Inc., Bloomington, Indiana, USA), 11 Ankura
grafts (Lifetech, Shenzhen, P. R. China) and four Aegis grafts
(MicroPort, Shanghai, P. R. China). The overall procedure
success rate was 84.3%.
In group A, 77 stent grafts were used, with a mean of
1.07 0.26 per patient. The procedure was successful in
88.9% of patients. There were 25 patients (34.7%) who
underwent stent-graft placement with LSA occluded inten-
tionally without re-vascularisation. Eight cases (11.1%) of
typeendoleakwere identifiedat theendof theseprocedures.
In group B, 53 stent grafts were used, with a mean of
1.08 0.34 per patient. The procedure was successful in
77.6% of patients. Intentional coverage of LSA without
reconstruction was performed in 11 patients (22.4%).
Reconstruction of LSA (left common carotid arteryeLSA
bypass) prior to over-stenting was performed in one patient
successfully. Type I endoleaks were observed in 11 patients
(22.4%) at the end of the procedure. Access complications
(iliac artery rupture) occurred in three patients (6.1%), and
were treated by a bypass or direct repair for the iliac artery.
Based on the variables described above, no significant
differenceswere found between groups A and B (Table 2). No
emergent surgical conversion was required in either group.
In-hospital and 30-day outcomes
In group A, the 30-day mortality was 1.4%. One patient with
an emergent condition of shock and aortic rupture died of
Table 1 Patient demographics
AAD (group A, nZ 72) CAD (group B, nZ 49) p
Age (years) 72 56.4 11.3 49 57.1 10.0 0.698
Male gender 65 90.3% 46 93.9% 0.712
Hypertension 71 98.6% 47 95.9% 0.734
Chronic renal failure 2 2.8% 3 6.1% 0.658
Chronic heart failure 1 1.4% 1 2.0% 1.000
Aortic rupture 3 4.2% 2 4.1% 1.000
Pneumonia 0 0% 2 4.1% 0.316
Cardiac arrhythmia 1 1.4% 1 2.0% 1.000
Marfan’s syndrome 0 0% 1 2.0% 0.846
Tumour 2 2.8% 3 6.1% 0.658
Malperfusion syndrome 15 20.8% 0 0% 0.002
Mild renal insufficiencya 5 6.9% 0 0% 0.060
Mild limb ischaemia 10 13.9% 0 0% 0.006
Number of tears 72 2.08 1.52 49 2.27 1.72 0.541
a Serum creatinine: 1.2e1.9 mg/dL.
Table 3 30-Day mortality and morbidity
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strokes (4.2%), all of which were minor without severe
sequelae. One patient presented with acute heart failure
with a complete recovery 5 days later. All the acute
patients were free from spinal cord ischaemia (SCI), renal
failure, respiratory failure, pneumonia and access compli-
cation. Six endoleaks disappeared spontaneously within 30
days, two endoleaks remained, yielding a 1-month endo-
leak rate of 3.1%. Complete FL thrombosis was documented
in 32.3% of patients.
In group B, the 30-day mortality was 8.2%. Four patients
died within 30 days. The first patient with co-morbid
pneumonia and cardiac arrhythmia died of multiple organ
failure on the fourth postoperative day. The second patient
with a history of chronic obstructive pulmonary disease and
Marfan syndrome died of myocardial infarction. The third
patient with previous aortic rupture and upper gastroin-
testinal bleeding died of a new rupture of the aorta. The
fourth patient with aortic rupture before intervention died
of pulmonary embolism. There was one stroke (2.0%),
which resulted in a persistent vegetative state of the
patient. The incidences of heart failure, respiratory failure,
pneumonia and access complication were 6.1%, 2.0%, 6.1%,
and 4.1%, respectively. Renal failure was not observed. The
rate of complete FL thrombosis was 26.2%. Based on
mortality and complications, no significant differences
were found between groups A and B.
Intentional over-stenting of LSA without previous re-
vascularisation was performed in 36 patients (29.8%). TwoTable 2 Procedure data
AAD (group A,
nZ 72)
CAD (group B,
nZ 49)
p
Stent graft 77 1.07 0.26 53 1.08 0.34 0.824
Procedure success 64 88.9% 38 77.6% 0.153
Coverage of LSA 25 34.7% 11 22.4% 0.212
Access complication 0 0% 3 6.1% 0.126
Postoperative
endoleak
8 11.1% 11 22.4% 0.153strokes (5.6%) occurred among these patients. The first
patient had an infarction in the frontal lobe with complete
rehabilitation 2 weeks later. The second patient had a cere-
bellar infarction and remained in a persistent neurological
vegetative state during follow-up. However, all the other
patients tolerated the occlusion of LSA well, without cere-
bral infarction, left subclavian steal syndrome or left upper
extremity ischaemia. Among the other 84 patients in whom
blockage of LSAwas not necessary during the procedure, two
strokes (2.4%) occurred. The incidence of stroke between
these two groups was not significantly different.
Follow-up data
In group A, the mean follow-up period was 14.4 11.0
months. Five patients were lost to follow-up. One patient
died of aortic rupture during follow-up. The survival rates
at 1 month, 1, 2 and 3 years postoperatively were 98.6%,
94.7%, 87.5% and 75.0%, respectively. The rates of
complete FL thrombosis at 1 and 2 years postoperatively
were 51.4% and 53.8%, respectively. The rates of partial FL
thrombosis at 1 and 2 years postoperatively were 48.6% and
46.2%, respectively.
In group B, the mean follow-up was 22.1 20.8 months,
significantly longer than that of group A (pZ 0.021). ThreeAAD (group A,
nZ 72)
CAD (group B,
nZ 49)
p
30-Day mortality 1 1.4% 4 8.2% 0.170
Stroke 3 4.2% 1 2.0% 0.901
Spinal cord
ischaemia
0 0% 0 0% e
Heart failure 1 1.4% 3 6.1% 0.362
Respiratory failure 0 0% 1 2.0% 0.846
Pneumonia 0 0% 3 6.1% 0.126
Access complication 0 0% 2 4.1% 0.316
1-Month endoleak 2 3.1% 5 12.5% 0.140
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the follow-up. The first patient with co-morbid conditions
of chronic renal and heart failure, polycystic liver and
kidney disease pre-interventionally died of massive post-
operative bleeding following a combined liverekidney
transplantation performed 42 days after the endovascular
repair. The second patient died of pulmonary infection 3
months after endovascular repair. The survival rates at 1
month, 1, 2 and 3 years postoperatively were 91.8%, 82.9%,
75.0% and 64.7%, respectively. There were no significant
differences related to survival rates between the two
groups (Fig. 1). The rates of complete FL thrombosis at 1
and 2 years postoperatively were 44.8% and 50.0%,
respectively. The rates of partial FL thrombosis at 1 and 2
years postoperatively were 55.2% and 50.0%, respectively.
Discussion
Currently, a consensus has been reached on themanagement
of B-AD. Intensive medical therapy including anti-
hypertensive treatment and the use of beta-blockers is the
first choice, with surgery reserved for patients complicated
with rupture or impending rupture, malperfusion syndrome
and rapid aortic expansion.8 Endovascular repair for patients
with B-AD has achieved favourable short- and mid-term
outcomes,9 compared to the traditional open surgery that is
still associatedwith relatively highmortality andmorbidity.3
A meta-analysis done by Eggebrecht et al. found
decreased mortality in treating the patients at chronic
phase compared to acute phase.6 However, this was not
observed in the study by Sayer et al., which reported
a mortality of 7.5% in chronic dissections compared to 2.6%
in acute dissections.10 We observed similar outcomes in
these two groups. It was reported that the more stable
clinical status of the patients in the chronic phase wasFigure 1 KaplaneMeier survival estimates of patients
treated for AAD in comparison to patients with CAD. The
difference in cumulative survival between the two groups is
not significant (PZ 0.18).probably the most important determinant of better survival
following endovascular repair.11 In our cohort, the co-
morbid conditions and clinical status (with the exception of
malperfusion syndrome) are comparable in the acute and
chronic groups, which is a possible reason for similar
outcomes in these two groups. The patients complicated
with aortic rupture or shock have been shown to be asso-
ciated with increased early mortality.12,13 In group A, one
patient with an emergent condition of shock and aortic
rupture died of a new rupture 2 days postoperatively. In
group B, both patients with rupture died even after the
stent graft was successfully deployed. The postoperative
mortality was as high as 60% for the patients with aortic
rupture. Differences in clinical status appear to have
a greater impact on outcome than the phase during which
treatment was implemented. Thus, when deciding on the
optimal time for stenting, clinical status should deserve
more attention than the phase.
Open repair of B-AD is associated with a relatively high
incidence of neurological deficits. IRAD investigators3
reported neurological deficits in 23.2% of patients treated by
traditional surgery, with stroke in 9.0% and SCI in 4.5%,
respectively. However, the EUROSTAR trial reported much
lower rates of stroke (1.6%) and SCI (0.8%) for endovascular
treatment of aortic dissections.14 In our cohort, the rate of
stroke and SCI was 3.3% and 0%, respectively. It is commonly
believed that stroke is associated with the manipulation of
guidewire or stent-graft delivery system within the aortic
arch. Amabile et al.15 found that the number of stent grafts
deployed and the extensive coverage of aortic segments
were predictive factors for SCI. Buth et al.16 reported that
independent correlation with SCI was observed for three or
more stent grafts used and LSA covering without re-
vascularisation. In our study, three stent grafts were used in
only one case, while one or two stent grafts were used in all
other cases. Themean number of stents used per patientwas
1.1. The low number of stents used per patient may explain
the absence of SCI in our cohort. However, with absence of
paraplegia or paraparesis, our results did not support that
LSA covering without re-vascularisation is a contributing
factor for causing SCI.
The relatively low rates of complete FL thrombosis in our
study may be attributed to the high rates of multiple tears
and small number of stents used. Previous studies found
that complete FL thrombosis was a predictor of reduced
aortic enlargement and dissection-related mortality.17,18
Patients with CAD demonstrate relatively poor ability to re-
model the aorta, and the rates of FL thrombosis distal to
the stent graft are particularly poor, indicating that a long
length of aortic coverage is required to gain better FL
thrombosis and aortic remodelling.10 However, when
extensive coverage of aorta is indicated for CAD, the
benefit of reducing aortic rupture and aneurysm expansion
should be balanced against the risk of SCI. Our policy with
chronic dissecting aneurysms was initially to cover the
primary entry tear with one longer stent, and only consider
further intervention if the FL was still patent several
months later. Although this procedure has reduced the rate
of SCI, it also caused a low rate of complete FL thrombosis.
Though increased dissection-related mortality has not been
observed, more careful imaging surveillance is necessary to
detect possible aortic enlargement and rupture for the
426 C. Guangqi et al.chronic patients in our cohort. More recently, we use more
than one stent to cover more extensively the primary entry
tear and the dissecting aneurysm.
Sufficient PLZ is of great importance to ensure complete
coverage of the proximal entry tear and to reduce the risk of
a type I endoleak. There is still a controversy on the safety of
intentionally overstenting the LSA, when the length of PLZ is
insufficient.19e22 Thirty-six patients had LSA covered simul-
taneously, without previous re-vascularisation. Two strokes
(5.6%) occurred in these patients, only one of which was
a posterior stroke. Thus, our LSA coverage-related stoke rate
of 2.8%, which is relatively low and acceptable. The rate of
stroke between these 36 patients and other 84 patients
without LSA coverage was not significantly different. Thus,
over-stenting of the LSA appears to be well tolerated in the
majority of patients, with a low rate of neurological deficits.
However, considering the severe sequelae of posterior
stroke, careful radiographic evaluation is necessary prior to
intentional over-stenting of LSA. In the condition of a patent
and dominant contralateral vertebral and a documented
intact vertebrobasilar system and the Willis circle, it seems
relatively safe to cover the LSA without re-vascularisation in
order to have a sufficient PLZ.
Conclusion
Our study shows that endovascular repair of acute and
chronic B-AD is feasible with a high immediate success rate
and a low rate of complications. Both early and mid-term
outcomes appear to be encouraging. Nevertheless, further
investigations are warranted to demonstrate its long-term
durability.
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